What is CG Oncology's net margin?

CG Oncology (CGON) reported net margin of -3,682.6% in Q1 2026.

How has CG Oncology's net margin changed year-over-year?

CG Oncology's net margin increased by 76.9% year-over-year, from -15,945.2% to -3,682.6%.

What is the long-term trend for CG Oncology's net margin?

Over 2 years (2023 to 2025), CG Oncology's net margin has grown at a -59.1% compound annual growth rate (CAGR), from -23,827% to -3,985%.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

CG Oncology CGON Net margin

Net margin at other companies

PfizerPFE

15.7%—

Johnson & JohnsonJNJ

21.8%-2.6pp

Gilead SciencesGILD

31%+10.2pp

ImmunityBio, Inc.IBRX

-606.2%-212pp

Tango TherapeuticsTNGX

-188.2%-55.4pp

Summit TherapeuticsSMMT

-271,685%-275,966pp

Other financials

Income statement

See full

Revenue$1.1M+1,983%

Operating income-$66.4M-57.3%

Net income-$60.2M-74.7%

EPS (diluted)-$0.71-57.8%

Balance sheet

See full

Cash & equivalents$33.7M-18.7%

Total debt$7.6M+631%

Total equity$1.1B+54.9%

Total assets$1.1B+55.9%

Cash flow

See full

Operating cash flow-$56.9M-94.5%

CapEx$304.0K+1,800%

Free cash flow-$57.2M-95.4%

Valuation

See full

Market cap$5.39B+206%

Profitability

See full

Operating margin-4,239%-1,872pp

FCF margin-3,163.8%-1,351pp

Returns & leverage

See full

Return on equity-20.8%+7.1pp

Debt / equity0×0.0×

Current ratio31.3×+0.3×

Where this comes from

Calculated from CG Oncology’s reported figures.

net income/total revenue=-3,682.6%

Based on trailing twelve months.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CG Oncology's net margin?: CG Oncology (CGON) reported net margin of -3,682.6% in Q1 2026.
How has CG Oncology's net margin changed year-over-year?: CG Oncology's net margin increased by 76.9% year-over-year, from -15,945.2% to -3,682.6%.
What is the long-term trend for CG Oncology's net margin?: Over 2 years (2023 to 2025), CG Oncology's net margin has grown at a -59.1% compound annual growth rate (CAGR), from -23,827% to -3,985%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.